Medicine Man Technologies, Inc. (SHWZ) Financial Statements (2024 and earlier)
Company Profile
Business Address |
865 N. ALBION ST. DENVER, CO 80220 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 8742 - Management Consulting Services (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 39,404 | 106,400 | 1,231 | 11,854 | 322 | 749 | |||
Cash and cash equivalents | 38,949 | 106,400 | 1,231 | 11,854 | 322 | 749 | |||
Short-term investments | 454 | ||||||||
Receivables | 4,484 | 3,867 | 1,533 | 1,154 | 2,587 | 678 | |||
Inventory, net of allowances, customer advances and progress billings | 22,554 | 11,122 | 2,619 | 685 | 489 | 106 | |||
Inventory | 22,554 | 11,122 | 2,619 | 685 | 489 | 106 | |||
Prepaid expense | 614 | 1,347 | |||||||
Other current assets | 529 | 51 | 43 | ||||||
Other undisclosed current assets | 5,293 | 2,523 | |||||||
Total current assets: | 71,735 | 123,912 | 5,997 | 15,569 | 3,449 | 1,576 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 18,199 | 8,512 | 2,579 | 60 | ✕ | ✕ | |||
Nontrade receivables | 303 | 3,064 | 3,064 | ||||||
Property, plant and equipment | 27,089 | 10,253 | 2,585 | 239 | 95 | 150 | |||
Long-term investments and receivables | 2,000 | 637 | 277 | 242 | |||||
Long-term investments | 2,000 | 494 | 277 | ||||||
Accounts and financing receivable, after allowance for credit loss | 143 | 242 | |||||||
Intangible assets, net (including goodwill) | 202,332 | 140,899 | 56,129 | 12,380 | 12,386 | 9,392 | |||
Goodwill | 94,605 | 43,316 | 53,047 | 12,304 | 12,304 | 9,304 | |||
Intangible assets, net (excluding goodwill) | 107,727 | 97,582 | 3,082 | 75 | 81 | 88 | |||
Disposal group, including discontinued operation, noncurrent assets | |||||||||
Deferred income tax assets | ✕ | ✕ | |||||||
Other noncurrent assets | 1,527 | 515 | 52 | 15 | |||||
Other undisclosed noncurrent assets | 675 | 2,292 | |||||||
Total noncurrent assets: | 251,148 | 161,119 | 64,685 | 16,659 | 14,772 | 9,557 | |||
TOTAL ASSETS: | 322,883 | 285,031 | 70,683 | 32,229 | 18,222 | 11,132 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 18,164 | 10,169 | 6,214 | 1,793 | 1,077 | 123 | |||
Taxes payable | ✕ | ✕ | 2,028 | 583 | |||||
Employee-related liabilities | ✕ | ✕ | 2 | ||||||
Accounts payable | 7,849 | 2,549 | 3,508 | 700 | 203 | 123 | |||
Accrued liabilities | 10,315 | 5,592 | 2,705 | 1,091 | 291 | ||||
Deferred revenue | 50 | ✕ | ✕ | ||||||
Debt | 2,250 | ||||||||
Derivative instruments and hedges, liabilities | 16,508 | 34,923 | 1,047 | 3,773 | |||||
Other liabilities | 56 | ||||||||
Due to related parties | ✕ | 22 | 171 | 5,049 | 15 | 71 | 155 | ||
Other undisclosed current liabilities | 10,437 | (0) | |||||||
Total current liabilities: | 47,381 | 45,263 | 12,360 | 5,582 | 1,148 | 335 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 125,522 | 106,198 | 16,547 | 67 | |||||
Long-term debt, excluding current maturities | 125,522 | 97,482 | 13,902 | ||||||
Liabilities, other than long-term debt | 17,817 | ||||||||
Deferred income tax liabilities | 502 | ✕ | ✕ | ||||||
Operating lease, liability | 17,314 | 8,715 | 2,646 | 67 | ✕ | ✕ | |||
Other undisclosed noncurrent liabilities | (8,715) | (2,646) | 58 | ||||||
Total noncurrent liabilities: | 143,338 | 106,198 | 16,547 | 67 | 58 | ||||
Total liabilities: | 190,719 | 151,461 | 28,908 | 5,649 | 1,148 | 393 | |||
Equity | |||||||||
Equity, attributable to parent | 132,163 | 133,570 | 41,775 | 26,580 | 17,074 | 10,739 | |||
Preferred stock | 0 | 0 | 0 | ||||||
Common stock | 56 | 45 | 43 | 40 | 28 | 23 | |||
Treasury stock, value | (2,033) | (1,517) | (1,333) | (1,000) | |||||
Additional paid in capital | 180,382 | 162,815 | 85,358 | 50,356 | 20,239 | 13,997 | |||
Accumulated deficit | (46,242) | (27,774) | (42,293) | (22,816) | (5,841) | (6,790) | |||
Other additional capital | 2,647 | 3,508 | |||||||
Total equity: | 132,163 | 133,570 | 41,775 | 26,580 | 17,074 | 10,739 | |||
TOTAL LIABILITIES AND EQUITY: | 322,883 | 285,031 | 70,683 | 32,229 | 18,222 | 11,132 |
Income Statement (P&L) ($ in thousands)
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 159,379 | 108,420 | 24,001 | 12,401 | 9,443 | 3,530 | ||
Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,530 | |
Cost of revenue | (74,349) | (59,067) | (17,226) | (7,616) | (2,578) | (1,302) | ||
Cost of goods and services sold | (59,067) | (17,226) | (7,616) | (2,307) | (1,034) | |||
Gross profit: | 85,030 | 49,354 | 6,774 | 4,785 | 6,865 | 2,227 | ||
Operating expenses | (72,175) | (38,945) | (29,677) | (21,867) | (4,695) | (7,463) | ||
Operating income (loss): | 12,855 | 10,409 | (22,903) | (17,082) | 2,170 | (5,236) | ||
Nonoperating income (expense) | (16,424) | 8,506 | 2,587 | (477) | (638) | (160) | ||
Other nonoperating income (expense) | 24 | (145) | ||||||
Interest and debt expense | (7,014) | (86) | ||||||
Income (loss) from continuing operations before income taxes: | (3,570) | 11,901 | (20,316) | (17,559) | 1,532 | (5,482) | ||
Income tax expense (benefit) | (14,898) | (4,396) | 899 | 583 | (583) | |||
Income (loss) from continuing operations: | (18,468) | 7,505 | (19,417) | (16,976) | 949 | (5,482) | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | 7,505 | (19,417) | (16,976) | 949 | (5,482) | |
Other undisclosed net income | 11,410 | |||||||
Net income (loss): | (18,468) | 18,915 | (19,417) | (16,976) | 949 | (5,482) | ||
Other undisclosed net income (loss) attributable to parent | (4,396) | 100 | ||||||
Net income (loss) attributable to parent: | (18,468) | 14,519 | (19,417) | (16,976) | 949 | (5,381) | ||
Preferred stock dividends and other adjustments | (7,803) | (7,346) | ||||||
Other undisclosed net loss available to common stockholders, basic | ||||||||
Net income (loss) available to common stockholders, basic: | (26,270) | 7,173 | (19,417) | (16,976) | 949 | (5,381) | ||
Other undisclosed net income (loss) available to common stockholders, diluted | (12,766) | |||||||
Net income (loss) available to common stockholders, diluted: | (26,270) | (5,593) | (19,417) | (16,976) | 949 | (5,381) |
Comprehensive Income ($ in thousands)
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (18,468) | 18,915 | (19,417) | (16,976) | 949 | (5,482) | ||
Comprehensive income (loss): | (18,468) | 18,915 | (19,417) | (16,976) | 949 | (5,482) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (7,803) | (4,396) | 100 | |||||
Comprehensive income (loss), net of tax, attributable to parent: | (26,270) | 14,519 | (19,417) | (16,976) | 949 | (5,381) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.